The clinical application of fluocinolone acetonide in the management of non-infectious posterior uveitis:interpretation of the European Expert Consensus 2024
10.13389/j.cnki.rao.2025.0045
- VernacularTitle:醋酸氟轻松在非感染性后葡萄膜炎治疗中的应用——2024年欧洲专家共识解读
- Author:
Yi SHAO
1
;
Xuanyi LI
;
Qian WEI
Author Information
1. 200080 上海市,上海交通大学医学院附属第一人民医院眼科
- Publication Type:Journal Article
- Keywords:
non-infectious posterior uveitis;
fluocinolone acetonide intravitreal implants;
treatment;
consensus
- From:
Recent Advances in Ophthalmology
2025;45(4):253-256
- CountryChina
- Language:Chinese
-
Abstract:
Non-infectious posterior uveitis(NIU-PS) is an ocular inflammatory disease that can cause eye structural damage and vision loss if inflammation reoccurs and is not effectively controlled.Achieving sustained disease control and preventing relapses are the primary therapeutic objectives.Recently,fluocinolone acetonide(FAc) intravitreal implants have received attention as a new local treatment option.Standardizing inflammation management has become a critical con-cern for ophthalmologists.This paper provides a detailed interpretation of the European expert consensus on the use of 0.2μg·d-1 FAc intravitreal implants for the treatment of NIU-PS patients.
